Larvol Delta - Caliway-Makes-First-ECO-2026-Oral-Presentation-on-Preclinical-Data-of-CBL514-in-Combination-with-GLP1RBased-WeightLoss-Therapies-Attracting-Strong-Interest-from-International-Experts-and-Global-Pharmaceutical-Companies-for-Its-Systemic-Metabolic-Effects

CBL-514 - Caliway Biopharmaceuticals

https://www.prnewswire.com/news-releases/caliway-makes-first-eco-2026-oral-presentation-on-preclinical-data-of-cbl-514-in-combination-with-glp-1r-based-weight-loss-therapies-attracting-strong-interest-from-international-experts-and-global-pharmaceutical-companies-for-it-302775692.html

May 19, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next